PT Kalbe Farma Tbk.
Symbol: PTKFY
PNK
17.03
USDDzisiejsza cena rynkowa
0.0056
Wskaźnik P/E
0.0000
Wskaźnik PEG
3.94B
Kapitalizacja MRK
- 0.03%
Rentowność DIV
PT Kalbe Farma Tbk. (PTKFY) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3397916.9 | 263.9 | 455.6 | |||||
balance-sheet.row.short-term-investments | 0 | 165496.3 | 9.4 | 18.2 | |||||
balance-sheet.row.net-receivables | 0 | 5628331.7 | 308.5 | 249.4 | |||||
balance-sheet.row.inventory | 0 | 6791979.8 | 460 | 363.3 | |||||
balance-sheet.row.other-current-assets | 0 | 99495.7 | 44.4 | 37.2 | |||||
balance-sheet.row.total-current-assets | 0 | 15917724.1 | 1076.8 | 1105.6 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 8537934.7 | 535.8 | 586.3 | |||||
balance-sheet.row.goodwill | 0 | 479347.4 | 30.9 | 14.8 | |||||
balance-sheet.row.intangible-assets | 0 | 1327234.2 | 1066868.8 | 961154.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1806581.6 | 1546216.2 | 1170837.9 | |||||
balance-sheet.row.long-term-investments | 0 | 285302.3 | 24.8 | 21.3 | |||||
balance-sheet.row.tax-assets | 0 | 136102.6 | 8.2 | 6.5 | |||||
balance-sheet.row.other-non-current-assets | 0 | 373922.8 | -1546106.4 | -1170751.6 | |||||
balance-sheet.row.total-non-current-assets | 0 | 11139844.1 | 678.6 | 700.4 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.account-payables | 0 | 1690719.6 | 128.7 | 117.3 | |||||
balance-sheet.row.short-term-debt | 0 | 299759.4 | 55.1 | 6.6 | |||||
balance-sheet.row.tax-payables | 0 | 225196.6 | 13.8 | 19 | |||||
balance-sheet.row.long-term-debt-total | 0 | 318778.9 | 18.5 | 34.5 | |||||
Deferred Revenue Non Current | 0 | 0 | 1.6 | 3 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 1252689.5 | 87.9 | 105.7 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 694377.6 | 45.9 | 60.9 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 41907.5 | 1.6 | 3 | |||||
balance-sheet.row.total-liab | 0 | 3937546.2 | 331.5 | 309.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 468751.2 | 30.2 | 33 | |||||
balance-sheet.row.retained-earnings | 0 | 21162752.5 | 1300.8 | 1299.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 53.5 | 49.4 | 47.7 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | -212700.7 | -66.9 | -2.5 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 21418856.5 | 1313.6 | 1377.7 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.minority-interest | 0 | 1701165.5 | 110.3 | 118.7 | |||||
balance-sheet.row.total-equity | 0 | 23120022 | 1423.9 | 1496.3 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 450798.6 | 34.1 | 39.6 | |||||
balance-sheet.row.total-debt | 0 | 618538.4 | 75.2 | 44.1 | |||||
balance-sheet.row.net-debt | 0 | -2613882.2 | -179.3 | -393.3 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 181.1 | 228.4 | 222.4 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.4 | 47.1 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-non-cash-items | 0 | -35.9 | -191.1 | -68.6 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.acquisitions-net | 0 | 63609.6 | -44.9 | 82.8 | |||||
cash-flows.row.purchases-of-investments | 0 | -173704.2 | -8.6 | -17.5 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 4.7 | 16.7 | 8.5 | |||||
cash-flows.row.other-investing-activites | 0 | 148275.5 | -0.3 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1140786.7 | -95.9 | 3.8 | |||||
cash-flows.row.debt-repayment | 0 | -2513595.4 | -24.2 | -35.4 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | -2.6 | 0 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -67.7 | 0 | |||||
cash-flows.row.dividends-paid | 0 | -1757714.4 | -110.2 | -91.7 | |||||
cash-flows.row.other-financing-activites | 0 | 35572 | 44.6 | -6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2443986.3 | -160 | -133.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -40050.4 | 237776.4 | -16432.5 | |||||
cash-flows.row.net-change-in-cash | 0 | -717348.3 | -182.9 | 65.7 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 3232420.6 | 254.5 | 437.4 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3949768.9 | 437.4 | 371.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 193.1 | 86.8 | 200.9 | |||||
cash-flows.row.capital-expenditure | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.free-cash-flow | 0 | -1178779.2 | 28 | 131 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 30449134.1 | 1953.9 | 1834.5 | |||||
income-statement-row.row.cost-of-revenue | 0 | 18625888.5 | 1189.7 | 1073.3 | |||||
income-statement-row.row.gross-profit | 0 | 11823245.5 | 764.2 | 761.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.operating-expenses | 0 | 8198108.5 | 481.4 | 483.3 | |||||
income-statement-row.row.cost-and-expenses | 0 | 26823997 | 1671.1 | 1556.5 | |||||
income-statement-row.row.interest-income | 0 | 88217.6 | 5.5 | 7.7 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.total-operating-expenses | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 333650.2 | 49.4 | 47.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 3672252.6 | 282.8 | 277.9 | |||||
income-statement-row.row.income-before-tax | 0 | 3606237.2 | 301.1 | 289.4 | |||||
income-statement-row.row.income-tax-expense | 0 | 827832.4 | 68.1 | 63.7 | |||||
income-statement-row.row.net-income | 0 | 2766748 | 228.4 | 222.4 |
Często zadawane pytania
Ile wynosi PT Kalbe Farma Tbk. (PTKFY) aktywów ogółem?
PT Kalbe Farma Tbk. (PTKFY) całkowite aktywa to 27057568182323.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.370.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -1793.009.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.089.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.123.
Co to jest PT Kalbe Farma Tbk. (PTKFY) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 2766748040055.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 618538351178.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 8198108504360.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.